Patient knowledge of fecal calprotectin in inflammatory bowel disease (IBD): An observational study in Mexico.
Ontology highlight
ABSTRACT: Background: Fecal calprotectin (FC) can be a valuable tool to optimize health care for patients with inflammatory bowel disease (IBD). The objective of this observational study was to determine the level of knowledge of the FC test in Mexican patients with IBD. Methods: A self-report questionnaire was distributed via Facebook to patients with IBD. The survey consisted of 15 questions in two categories: the first category assessed knowledge of IBD diagnosis, and the second category assessed knowledge of the FC test. Results: In total, 460 patients with IBD participated, of which 83.9% (386) had ulcerative colitis (UC) and 16.0% (74) had Crohn's disease (CD). Regarding IBD diagnosis, 41.9% of participants stated that they did not know of a non-invasive test for fecal mat
SUBMITTER: Maldonado-Arriaga B
PROVIDER: S-EPMC9418753 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature
ACCESS DATA